U.S FDA Approves AQVESME; (mitapivat) for Adults with Thalassemia

On December 23, 2025, the U.S. Food and Drug Administration (FDA) approved AQVESME™ (mitapivat) for the treatment of anemia in adults with alpha- or beta-thalassemia.